Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
84 pending office actions • 51 clients • 76 examiners • 55 art units • 0 of 84 (0%) have an AI response strategy ready
CHALKER FLORES, LLP handles 4165 career applications in the Biotechnology & Pharmaceuticals technology area. The firm currently has 66 pending office actions and a resolved allowance rate of 82.52 percent.
The firm averages 4.43 office actions per allowance. This metric reflects the number of responses typically required to reach a favorable outcome in the life sciences. For practitioners, the 82.52 percent allowance rate and the 4.43 average office actions per allowance provide a benchmark for the expected success and the procedural duration of the examination process.
Based on the USPTO statutory response window for each pending office action. 40 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 40 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (2%) |
| §101 + other | 11 (13%) |
| §103 only | 19 (23%) |
| §102 only | 2 (2%) |
| §112 only | 8 (10%) |
| Double-patenting only | 2 (2%) |
| Double-patenting + other | 13 (15%) |
| Multi-statute (no §101) | 27 (32%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BONAPARTE, AMY C | 2 | 79.3% | +23.2% |
| LITTLE, ANNA VICTORIA | 2 | 76.7% | +23.3% |
| GALSTER, SAMUEL LEONARD | 2 | 50.9% | +43.2% |
| GREEN, MALIA NICOLE | 2 | — | — |
| FIEBIG, RUSSELL G | 2 | 62.6% | +25.0% |
| WHITE, ASHLEY TAYLOR | 2 | 25.0% | +46.7% |
| FUBARA, BLESSING M | 2 | 62.2% | +34.3% |
| RENNER, BRANDON M | 2 | 81.2% | +20.9% |
| KIM, DANIELLE A | 1 | 37.1% | +56.3% |
| GOTFREDSON, GAREN | 1 | 40.0% | +28.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16853599 | Electronic Control Device | RENNER, BRANDON M | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17768537 | Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration | STEELE, AMBER D | 280d overdue |
| 17567400 | Wireless Communication Methods | RENNER, BRANDON M | 87d overdue |
| 18468050 | Hook-Spring Plate for Growth Modulation of Immature Rib to Correct Early Onset Scoliosis | RAMANA, ANURADHA | 73d overdue |
| 18137016 | DISTRIBUTED MICROWAVE QUANTUM COMPUTING SYSTEM | HOSSAIN, MOAZZAM | 67d overdue |
| 18322942 | ANALYSIS OF PROTEIN KINASES IN LIVE CELLS | WHITE, ASHLEY TAYLOR | 29d overdue |
| 17462414 | ROTORCRAFT FALL RESTRAINT PROTECTION ATTACH POINTS AND MECHANISM SYSTEMS | EDWARDS, LOREN C | 28d overdue |
| 18887482 | Method and System for Generating Solution Explanations for Learning Problems | UTAMA, ROBERT J | 15d overdue |
| 18296755 | EXOSOME ENCODED IL-10 AS A TREATMENT FOR INFLAMMATION ASSOCIATED ADVERSE PREGNANCY CONDITION | ABBAS, SYED JARAR | 5d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17567400 | Wireless Communication Methods | RENNER, BRANDON M | 87d overdue |
| 18322942 | ANALYSIS OF PROTEIN KINASES IN LIVE CELLS | WHITE, ASHLEY TAYLOR | 29d overdue |
| 19307513 | Sublingual Formulation of Anticancer Compound for Use in the Treatment of Autoimmune Neurodegenerative Diseases | GOTFREDSON, GAREN | 5d overdue |
| 18770850 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | BONAPARTE, AMY C | 14d |
| 18678550 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | BONAPARTE, AMY C | 14d |
| 18693693 | Triple Drug Combination (Metformin, Simvastatin, Digoxin) for Targeted Treatment of Colorectal Cancer | GALSTER, SAMUEL LEONARD | 63d |
| 17909480 | TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION | FUBARA, BLESSING M | 68d |
| 19539174 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE AND DERIVATIVES THEREOF, AND TABLETS THEREOF | KIM, DANIELLE A | — |
| Art Unit | Apps |
|---|---|
| 1613 | 4 |
| 3773 | 4 |
| 1653 | 4 |
| 1643 | 4 |
| 1642 | 3 |
| 1619 | 2 |
| 3715 | 2 |
| 1692 | 2 |
| 1655 | 2 |
| 1628 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19539174 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE AND DERIVATIVES THEREOF, AND TABLETS THEREOF | Nacuity Pharmaceuticals, Inc. | KIM, DANIELLE A | 1613 | §103§112DP | Non-Final OA | — | Pending | Feb 13, 2026 |
| 19307513 | Sublingual Formulation of Anticancer Compound for Use in the Treatment of Autoimmune Neurodegenerative Diseases | Vektor Pharma Tf GmbH | GOTFREDSON, GAREN | 1619 | §103DP | Non-Final OA | 5d overdue | Pending | Aug 22, 2025 |
| 19173475 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE, DERIVATIVES AND TABLETS THEREOF | Nacuity Pharmaceuticals, Inc. | KASSA, TIGABU | 1619 | §103§112 | Non-Final OA | 40d | Pending | Apr 08, 2025 |
| 19172058 | AUTOMATED CANINE LINE-UP FOR DETECTION DOG RESEARCH | Texas Tech University System | ABBOTT-LEWIS, YVONNE RENEE | 3644 | §102§103 | Non-Final OA | — | Pending | Apr 07, 2025 |
| 18975409 | Modified Tetracycline for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes | Texas Tech University System | COLEMAN, BRENDA LIBBY | §102§103§112DP | Non-Final OA | — | Pending | Dec 10, 2024 | |
| 18910067 | Crenolanib for Treating FLT3 Mutated Proliferative Disorders | Arog Pharmaceuticals, Inc. | GEMBEH, SHIRLEY V | DP | Non-Final OA | — | Pending | Oct 09, 2024 | |
| 18887252 | Method and System for Generating Learning Problems | Mata Edu, Inc. | FRENCH, CORRELL T | 3715 | §101§103§112 | Final Rejection | 60d | Pending | Sep 17, 2024 |
| 18887482 | Method and System for Generating Solution Explanations for Learning Problems | Mata Edu, Inc. | UTAMA, ROBERT J | 3715 | §101 | Final Rejection | 15d overdue | Pending | Sep 17, 2024 |
| 18823052 | Sealing System and Method for Pressurized Sand Damper | Southern Methodist University | KING, BRADLEY T | §102§103§112 | Non-Final OA | — | Pending | Sep 03, 2024 | |
| 18818731 | BIOMARKERS USEFUL IN THE TREATMENT OF SUBJECTS HAVING DISEASES OF THE EYE | The Johns Hopkins University | RAO, SAVITHA M | §102§103DP | Non-Final OA | — | Pending | Aug 29, 2024 | |
| 18814725 | Systems and Methods for Angiogenic Treatment in Wound Healing | Venturis Therapeutics, Inc. | MOLOYE, TITILAYO | §112DP | Non-Final OA | — | Pending | Aug 26, 2024 | |
| 18840269 | PROTEIN BIOMARKERS OF INFLAMMATORY ACTIVITY IN MULTIPLE SCLEROSIS | The Board Of Regents Of The University Of Oklahoma | COUNTS, GARY W | §101§112 | Non-Final OA | — | Pending | Aug 21, 2024 | |
| 18776848 | Method and System for Recording Clinical Trial Data Using Generative AI Model | Crscube, Inc. | ERICKSON, BENNETT S | 3683 | §101§103 | Non-Final OA | 3d overdue | Pending | Jul 18, 2024 |
| 18770850 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | Nacuity Pharmaceuticals, Inc. | BONAPARTE, AMY C | 1692 | §102§103 | Non-Final OA | 14d | Pending | Jul 12, 2024 |
| 18728142 | Microwave Architecture for Passive Sensing Applications | Texas Tech University System | GOOD, KENNETH W | 3648 | §103 | Final Rejection | — | Pending | Jul 11, 2024 |
| 18770014 | ANCHOR AND INTERBODY FOR INTERBODY FUSION | Evolution Spine, LLC | LITTLE, ANNA VICTORIA | 3773 | §103 | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18719116 | REVERSAL OF SENESCENCE BY ULTRASOUND IRRADIATION | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | CWERN, JONATHAN | 3797 | §102§103 | Final Rejection | — | Pending | Jun 12, 2024 |
| 18678550 | METHOD FOR PREPARATION OF N-ACETYL CYSTEINE AMIDE OR DI- N-ACETYL CYSTEINE AMIDE AND DERIVATIVES | Nacuity Pharmaceuticals, Inc. | BONAPARTE, AMY C | 1692 | §102§103 | Non-Final OA | 14d | Pending | May 30, 2024 |
| 18626439 | Preparation of Chitin Nanocrystals and Nanowhiskers from Crustacean Biomass Using Ionic Liquid | Texas Tech University System | GALSTER, SAMUEL LEONARD | §102§103§112 | Non-Final OA | — | Pending | Apr 04, 2024 | |
| 18697938 | Selenium Containing Antimicrobial Compound as a Reacitve Dye and Cross-Linking Treatment for Textile Applications | Texas Tech University System | STEVENS, MARK V | 1613 | §102§103§112DP | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18693693 | Triple Drug Combination (Metformin, Simvastatin, Digoxin) for Targeted Treatment of Colorectal Cancer | Whispergenics. Inc. | GALSTER, SAMUEL LEONARD | 1693 | §103DP | Non-Final OA | 63d | Pending | Mar 20, 2024 |
| 18692976 | Method for Promoting Production of Exopolysaccharide by Bifidobacterium Bacteria | Tohoku University | EPSTEIN, TODD MATTHEW | 1652 | §101§102§112 | Final Rejection | 75d | Pending | Mar 18, 2024 |
| 18688533 | Power Amplifier System in a Package | 3D Glass Solutions, Inc. | LEE, CHEUNG | 2812 | §103§112 | Non-Final OA | — | Pending | Mar 01, 2024 |
| 18685939 | Antibody Specifically Binding to CD47, Recombinant Oncolytic Virus Thereof and Use Thereof | Shanghai Sinobay Biotechnology Co., Ltd. | SHUPE, ELIZABETH A | §102§103§112Other | Non-Final OA | — | Pending | Feb 23, 2024 | |
| 18683442 | METHOD FOR TREATING IMMUNE DISEASES USING CALCINEURIN INHIBITOR AND STEM CELLS | Kangstem Biotech Co., Ltd. | BARRON, SEAN C | 1653 | §103 | Final Rejection | — | Pending | Feb 13, 2024 |
| 18390880 | VARIANT-SPECIFIC EXOGENOUS DNA TEMPLATE-FREE CORRECTION OF PATHOGENIC VARIANTS | Hadasit Medical Research Services And Development Ltd. | MEYERING, SHABANA SHABBEER | 4100 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 18568393 | REMOTELY CONTROLLABLE RESCUE VESSEL | Australian Droid & Robot Pty Ltd. | BURGESS, MARC R | 3615 | §103§112 | Non-Final OA | 23d | Pending | Dec 08, 2023 |
| 18564913 | Suppressive T Cell Populations and Methods of Cancer Immunotherapy | UNIVERSITY OF SOUTHAMPTON | GURLEY, JAMI MICHELLE | §101§103§112 | Non-Final OA | — | Pending | Nov 28, 2023 | |
| 18517623 | Non-Small Cell Lung Cancer Diagnosis and Treatment | West Virginia University | POHNERT, STEVEN C | 1683 | §103 | Non-Final OA | — | Pending | Nov 22, 2023 |
| 18506519 | PROX1 PREVENTS MYXOMATOUS VALVE DISEASE BY INHIBITING PDGF-B SIGNALING | Oklahoma Medical Research Foundation | KONOPKA, CATHERINE ANNE | 1635 | §112 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18499751 | SPINAL IMPLANT | Evolution Spine | LITTLE, ANNA VICTORIA | 3773 | §103 | Final Rejection | — | Pending | Nov 01, 2023 |
| 18492092 | COMPOSITIONS AND METHODS FOR THERMAL SKIN TREATMENT WITH METAL NANOPARTICLES | Coronado Aesthetics, LLC | YU, HONG | 1614 | §103 | Non-Final OA | 89d overdue | Pending | Oct 23, 2023 |
| 18489983 | CHEMOKINE RECEPTOR 8 (CCR8) ANTIBODIES | Ibio, Inc. | GREEN, MALIA NICOLE | 1643 | §112 | Non-Final OA | — | Pending | Oct 19, 2023 |
| 18484635 | EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III ANTIBODIES | Ibio, Inc. | GREEN, MALIA NICOLE | 1643 | §103§112 | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18482147 | Use of Black Solider Fly Larvae as Palatant / Palatability Enhancer for use in edible pet products | Npic | KOHLER, STEPHANIE A | 1791 | §103 | Final Rejection | 59d overdue | Pending | Oct 06, 2023 |
| 18470999 | Neuraminidase-Inhibited Influenza Virus | Vaxdome Inc. | FOLEY, SHANON A | 1671 | §103 | Final Rejection | — | Pending | Sep 20, 2023 |
| 18468050 | Hook-Spring Plate for Growth Modulation of Immature Rib to Correct Early Onset Scoliosis | Texas Scottish Rite Hospital For Children | RAMANA, ANURADHA | 3775 | §102§103§112 | Non-Final OA | 73d overdue | Pending | Sep 15, 2023 |
| 18044813 | METHOD FOR PREPARING INJECTABLE INJECTION COMPOSITION DERIVED FROM ANIMAL CARTILAGE, AND USE THEREOF | Kangstem Biotech Co., Ltd. | FIEBIG, RUSSELL G | 1655 | §103§112Other | Final Rejection | — | Pending | Aug 30, 2023 |
| 18457037 | CARDIOPROTECTIVE LIPIDS AND METHODS OF USE | Signpath Pharma, Inc. | O DELL, DAVID K | 1621 | §102§112 | Final Rejection | — | Pending | Aug 28, 2023 |
| 18342881 | NONINVASIVE WATER CONTENT SENSOR | Southern Methodist University | RODAK, LEE E | 2858 | §103 | Non-Final OA | 12d | Pending | Jun 28, 2023 |
| 18334212 | Compositions and Methods for Treating Osteonecrosis | Texas Scottish Rite Hospital For Children | CHANDRA, GYAN | 3783 | §102§103§112DP | Non-Final OA | — | Pending | Jun 13, 2023 |
| 18333812 | METHOD FOR PREPARING INJECTABLE INJECTION COMPOSITION DERIVED FROM ANIMAL CARTILAGE, AND USE THEREOF | Atems Co., Ltd. | FIEBIG, RUSSELL G | 1655 | §103§112 | Final Rejection | — | Pending | Jun 13, 2023 |
| 18256449 | BCAA-Lowering Compounds for Prevention and/or Treatment of Alzheimer's Disease and Related Disorders | Texas Tech University System | LADD, CAROLYN LOUISE | 1622 | §112 | Non-Final OA | 13d | Pending | Jun 08, 2023 |
| 18322942 | ANALYSIS OF PROTEIN KINASES IN LIVE CELLS | University of North Carolina - Chapel Hill | WHITE, ASHLEY TAYLOR | 1653 | §103§112DP | Final Rejection | 29d overdue | Pending | May 24, 2023 |
| 18035160 | HLA CLASS II-RESTRICTED TCRS AGAINST THE KRAS G12>V ACTIVATING MUTATION | The Regents of the University of California | GODDARD, LAURA B | 1642 | §102§112Other | Non-Final OA | — | Pending | May 03, 2023 |
| 18249988 | CARRIER PEPTIDE FRAGMENT AND USE THEREOF | Toagosei Co., Ltd. | NOAKES, SUZANNE MARIE | 1656 | §102 | Non-Final OA | — | Pending | Apr 21, 2023 |
| 18137016 | DISTRIBUTED MICROWAVE QUANTUM COMPUTING SYSTEM | Anyon Computing Inc. | HOSSAIN, MOAZZAM | 2898 | §102§103 | Final Rejection | 67d overdue | Pending | Apr 20, 2023 |
| 18296755 | EXOSOME ENCODED IL-10 AS A TREATMENT FOR INFLAMMATION ASSOCIATED ADVERSE PREGNANCY CONDITION | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | ABBAS, SYED JARAR | 1674 | §102§103§112 | Final Rejection | 5d overdue | Pending | Apr 06, 2023 |
| 18006300 | Flexible Intramedullary Device Tether | Texas Scottish Rite Hospital For Children | LANE, HOLLY JOANNA | 3773 | §102§103 | Final Rejection | 34d | Pending | Jan 20, 2023 |
| 18016538 | Methods and Compositions for Diagnosing and Treating Cancer | La Jolla Institute For Immunology | KIRWIN, STEFANIE JOHANNA | 1677 | §101§103§112 | Non-Final OA | 65d | Pending | Jan 17, 2023 |
| 18072100 | System, Kit and Apparatus for Attachment of External Fixators for Bone Realignment | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | COTRONEO, STEVEN J | 3773 | §103 | Non-Final OA | — | Pending | Nov 30, 2022 |
| 17925662 | Agent for Increasing Content of IgA Antibody in Milk | The University of Tokyo | KOROTCHKINA, LIOUBOV G | 1653 | §103 | Non-Final OA | 52d overdue | Pending | Nov 16, 2022 |
| 17971072 | MICROBIOME TRANSPLANTATION FOR OSTEOARTHRITIS THERAPY | The Board Of Regents Of The University Of Oklahoma | CRUM, MARY ABOU NADER | 1657 | §103§112 | Final Rejection | 34d | Pending | Oct 21, 2022 |
| 17956270 | MICRONUTRIENT DELIVERY TO GINGIVAL CREVICE | 3I Biotechnologies LLC | FUBARA, BLESSING M | 1613 | DPOther | Non-Final OA | — | Pending | Sep 29, 2022 |
| 17956249 | DISULFIRAM AND OTHER REDOX-RELATED COMPOSITIONS FOR BRAIN TUMORS | Texas Tech University System | BORI, IBRAHIM D | 1629 | §112 | Final Rejection | 86d | Pending | Sep 29, 2022 |
| 17947899 | AUTOMATED METHOD AND SYSTEM FOR INTERPRETING TEST RESULTS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | NEWTON, CHAD A | 3681 | §101§103 | Non-Final OA | — | Pending | Sep 19, 2022 |
| 17909480 | TARGETING JUNCTIONAL EPITHELIUM IN THE GINGIVAL CREVICE FOR IMMUNE MODULATION | Texas Tech University System | FUBARA, BLESSING M | 1613 | §103§112DPOther | Non-Final OA | 68d | Pending | Sep 06, 2022 |
| 17908999 | MODIFIED TETRACYCLINES FOR TREATMENT OF ALCOHOL USE DISORDER, PAIN AND OTHER DISORDERS INVOLVING POTENTIAL INFLAMMATORY PROCESSES | Texas Tech University System | HOWELL, THEODORE R | 1628 | §102DPOther | Final Rejection | 71d | Pending | Sep 02, 2022 |
| 17760402 | Coronavirus T Cell Epitopes and Uses Thereof | La Jolla Institute For Immunology | ALAM, DANYAL HASSAN | 1672 | §101§102§103§112 | Non-Final OA | — | Pending | Aug 10, 2022 |
| 17861673 | IDO/TDO Inhibitor | Canbas Co., Ltd. | BARSKY, JARED | 1628 | §103DP | Non-Final OA | 8d | Pending | Jul 11, 2022 |
| 17788993 | INDIVIDUALIZED VACCINES FOR CANCER TREATMENT AND PREVENTION | Mayo Foundation for Medical Education and Research | CANELLA, KAREN A | 1643 | §112 | Non-Final OA | — | Pending | Jun 24, 2022 |
| 17631934 | AGENT FOR PREVENTING OR TREATING MILD COGNITIVE IMPAIRMENT | National University Corporation Tokyo Medical And Dental University | D' AMBROSIO, THEA | 1654 | §112 | Final Rejection | 5d overdue | Pending | Jun 07, 2022 |
| 17782768 | METHOD AND COMPOSITIONS FOR ENGINEERING GRAPEVINE RED BLOTCH VIRUS-RESISTANT GRAPEVINE | Texas Tech University System | RADOSAVLJEVIC, ALEKSANDAR | 1662 | §103§112 | Non-Final OA | 13d | Pending | Jun 06, 2022 |
| 17779392 | Methods and Compositions for Modulationg Heterochromatin Dysfunction, Genomic Instability, and Associate Conditions | La Jolla Institute For Immunology | XIAO, YAN | 1642 | §112 | Non-Final OA | — | Pending | May 24, 2022 |
| 17777183 | Method for Collecting Data for Predicting Occurrence of Anaphylaxis | Applied Medical Enzyme Research Institute Corporation | FONSECA LOPEZ, FRANCINI ALVARENGA | 1685 | §101§103§112 | Final Rejection | — | Pending | May 16, 2022 |
| 17741518 | ANALYSIS OF PROTEIN KINASES IN LIVE CELLS | University of North Carolina - Chapel Hill | WHITE, ASHLEY TAYLOR | 1653 | §103§112 | Final Rejection | — | Pending | May 11, 2022 |
| 17768537 | Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration | Mayo Foundation for Medical Education and Research | STEELE, AMBER D | 1658 | §102§103§112 | Final Rejection | 280d overdue | Pending | Apr 13, 2022 |
| 17700591 | ANTIMICROBIAL PEPTIDES | Genvor Inc. | SHARMA, SANTOSH | 1663 | §103 | Non-Final OA | 65d | Pending | Mar 22, 2022 |
| 17701051 | TREATMENT OF FERROPTOSIS | Nacuity Pharmaceuticals, Inc. | CHONG, YONG SOO | 1623 | §103 | Final Rejection | 60d | Pending | Mar 22, 2022 |
| 17686222 | Male Incontinence Device | 4 Mankind Inc. | KALIHER, HANS CHRISTIAN | 3781 | §103 | Final Rejection | 68d | Pending | Mar 03, 2022 |
| 17591280 | CHITIN ANALOGS FOR THE TREATMENT OF KIDNEY DISEASES | AyuVis Research, Inc. | CRAIGO, BAHAR ALAWI | 1699 | §103 | Non-Final OA | 11d overdue | Pending | Feb 02, 2022 |
| 17625226 | Intratumoral TFR Cells Curtail Anti-PD-1 Treatment Efficacy | UNIVERSITY OF SOUTHAMPTON | DENT, ALANA HARRIS | 1643 | DP | Non-Final OA | 84d | Pending | Jan 06, 2022 |
| 17567400 | Wireless Communication Methods | Ilumi Solutions, Inc. | RENNER, BRANDON M | 2411 | §103§112 | Final Rejection | 87d overdue | Pending | Jan 03, 2022 |
| 17462414 | ROTORCRAFT FALL RESTRAINT PROTECTION ATTACH POINTS AND MECHANISM SYSTEMS | Textron Innovations Inc. | EDWARDS, LOREN C | 3746 | §102§103 | Non-Final OA | 28d overdue | Pending | Aug 31, 2021 |
| 17461812 | System, Method and Apparatus for Increasing Website Relevance While Protecting Privacy | Your Command, LLC | POPHAM, JEFFREY D | 2432 | §103§112 | Non-Final OA | 23d | Pending | Aug 30, 2021 |
| 17361763 | Personalized Medicine Approach for Treating Cognitive Loss | University Of North Texas Health Science Center AT Fort Worth | AKOGYERAM II, NICHOLAS A | 3686 | §101§112 | Non-Final OA | 27d | Pending | Jun 29, 2021 |
| 17339652 | TREATMENT OF CYSTINOSIS | Nacuity Pharmaceuticals, Inc. | KWON, JOHN SEUNGJAI | 1615 | §103 | Non-Final OA | — | Pending | Jun 04, 2021 |
| 17284525 | Method to Express, Purify, and Biotinylate Eukaryotic Cell-Derived Major Histocompatibility Complexes | Texas Tech University System | YAO, LEI | 1642 | §103 | Final Rejection | 35d overdue | Pending | Apr 12, 2021 |
| 17275398 | Industrial Scale Processes Form a Covalent Bonded Monomer and Graphene Oxide Structures | Garmor Inc. | FOSS, DAVID ROGER | 1764 | §102 | Non-Final OA | — | Pending | Mar 11, 2021 |
| 17251359 | PREDICTIVE 7-GENE ASSAY AND PROGNOSTIC PROTEIN BIOMARKER FOR NON-SMALL CELL LUNG CANCER | West Virginia University | HANEY, AMANDA MARIE | 1682 | §112 | Final Rejection | — | Pending | Dec 11, 2020 |
| 16853599 | Electronic Control Device | Ilumi Solutions, Inc. | RENNER, BRANDON M | 2411 | §103 | Non-Final OA | — | Pending | Apr 20, 2020 |
| 16312346 | Blood Test for Screening Out Amyloid and Alzheimers Disease Presence | University Of North Texas Health Science Center AT Fort Worth | CHERNYSHEV, OLGA N | 1675 | §101§112 | Non-Final OA | 70d | Pending | Dec 21, 2018 |
| 16035632 | SYSTEM AND METHOD FOR CREATING AN ELECTRONIC CONSENT-BASED MEDICAL RECORD | TruConsent | HOLCOMB, MARK | 3685 | §101 | Non-Final OA | — | Pending | Jul 14, 2018 |
| 15775712 | METHODS OF TREATING SKIN CONDITIONS USING PLASMONIC NANOPARTICLES | Coronado Aesthetics, LLC | BLAISE, BRADFORD CHRISTOPHER | 3794 | §103 | Non-Final OA | — | Pending | May 11, 2018 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial